Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dataset13_SUDHL4 6h Gemcitabine ATRi IMPRINTS

ABSTRACT: SUDHL4 cells were treated with vehicle control, 24uM gemcitabine alone, DMSO, 6uM AZD6738 alone, or 24uM Gemcitabine with 6uM AZD6738 for 6h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Liang Ying Yu

PROVIDER: PXD054911 | JPOST Repository | Thu Jun 12 00:00:00 BST 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20230201_KK_SUD_Gem_ATRi_6h_37_F1.raw	Raw
	20230201_KK_SUD_Gem_ATRi_6h_37_F10.raw	Raw
	20230201_KK_SUD_Gem_ATRi_6h_37_F11.raw	Raw
	20230201_KK_SUD_Gem_ATRi_6h_37_F12.raw	Raw
	20230201_KK_SUD_Gem_ATRi_6h_37_F13.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Dataset04_SUDHL4 3h 5h Gemcitabine IMPRINTS

Project description:SUDHL4 cells were treated with 24uM gemcitabine for 3h and 5h (with 5h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054901 | JPOST Repository

Dataset03_SUDHL4 1h 8h Gemcitabine IMPRINTS

Project description:SUDHL4 cells were treated with 24uM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054854 | JPOST Repository

Dataset14_SUDHL4 SAMHD1 KO 1h 8h Gemcitabine IMPRINTS

Project description:SUDHL4 SAMHD1 knockout cells were treated with 24uM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054912 | JPOST Repository

Dataset01_HT 1h 8h Gemcitabine IMPRINTS

Project description:HT cells were treated with 24uM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054852 | JPOST Repository

Dataset07_SUDHL4 1h 8h low dose 1 Gemcitabine IMPRINTS

Project description:SUDHL4 cells were treated with 480nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD055015 | JPOST Repository

Dataset08_SUDHL4 1h 8h low dose 2 Gemcitabine IMPRINTS

Project description:SUDHL4 cells were treated with 48nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD055016 | JPOST Repository

Dataset10_SUDHL4 5h Gemcitabine ITDR

Project description:SUDHL4 cells were treated with increasing gemcitabine concentrations (and vehicle control) for 5h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054908 | JPOST Repository

Dataset02_OCILY3 1h 8h Gemcitabine IMPRINTS

Project description:OCILY3 cells were treated with 280nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054853 | JPOST Repository

Dataset06_OCILY19 3h 5h Gemcitabine IMPRINTS

Project description:OCILY19 cells were treated with 48nM gemcitabine for 3h and 5h (with 5h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054903 | JPOST Repository

Dataset05_ OCILY19 1h 8h Gemcitabine IMPRINTS

Project description:OCILY19 cells were treated with 48nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.

2025-06-12 | PXD054902 | JPOST Repository

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data